Benign Uterine Ligament Neoplasm C0865093
A non-cancerous tumor developing in the ligaments that support the uterus. Typically found in women of reproductive age. Often managed with monitoring or surgical removal if symptomatic.
Key facts at a glance
- ICD-10
- N50.9
- ICD-11
- GA00.0
- Body system
- reproductive
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(reproductive)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Pelvic pressure
(reproductive)Abdominal fullness
(reproductive)Pelvic mass sensation
(reproductive)Lower back discomfort
(reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Watchful waiting with pelvic imaging
Regular pelvic ultrasound and clinical examination to monitor the benign ligamentous neoplasm without immediate intervention, appropriate for asymptomatic presentations.
Laparoscopic excision
Minimally invasive surgical removal of the benign neoplasm from the uterine ligament using laparoscopic techniques with small incisions.
Additional treatment options
Gonadotropin-releasing hormone agonists
Temporary hormonal suppression therapy that may reduce the size of hormone-sensitive ligamentous neoplasms prior to surgical intervention.
medicationUterine artery embolization
Interventional radiology technique to block blood supply to the ligamentous neoplasm, causing shrinkage and symptom relief.
procedureAcupuncture and pain management support
Traditional acupuncture and complementary pain management techniques may provide symptomatic relief for pelvic discomfort associated with the neoplasm.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Benign Uterine Ligament Neoplasm C0865093?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Stewart EA, Cookingham CL, Einarsson JI. Guidelines for the management of uterine leiomyomas. Obstet Gynecol. 2022;139(3):419-432.
Donnez J, Dolmans MM. Uterine fibroid management: from today to the future. Hum Reprod Update. 2021;27(4):647-662.
Manyonda I, Belli AM, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2021;384(14):1325-1336.
Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2020;12:CD005073.
Medication Comparisons
Compare medications used to treat Benign Uterine Ligament Neoplasm C0865093. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy